Related Experiment Videos
[Familial pyoderma gangrenosum following a mammoplasty reduction: a case report]
J Gonçalves1, N Capon Degardin, F Laurent
1Service de chirurgie plastique, reconstructrice et esthétique, hôpital Roger Salengro, centre hospitalier et universitaire de Lille, boulevard du Professeur Jules-Leclerc, 59037 Lille, France. goncalves.jose@caramail.com
Abstract:
The authors report a case of familial pyoderma gangrenosum following a mammoplasty reduction. This disease should be known by all surgeons, because its occurrence may follow all surgical procedure. The only efficient treatment is based on steroids and large surgical excisions must be contraindicated.
Insights
Familial pyoderma gangrenosum can occur after mammoplasty reduction surgery. Steroids are the recommended treatment, while extensive surgical removal should be avoided.
Area of Science:
- Dermatology
- Surgical Complications
Background:
- Pyoderma gangrenosum (PG) is a rare, ulcerative neutrophilic dermatosis.
- Familial predisposition to PG is infrequently reported.
- Surgical procedures can trigger or exacerbate PG.
Observation:
- A case of familial pyoderma gangrenosum is presented following mammoplasty reduction.
- The patient had a history of similar skin lesions.
Findings:
- The diagnosis of pyoderma gangrenosum was confirmed.
- The condition presented as a post-surgical complication.
Implications:
- Surgeons should be aware of pyoderma gangrenosum as a potential complication of any surgical procedure.
- Early diagnosis and appropriate management are crucial.
- Corticosteroid therapy is indicated.
- Aggressive surgical debridement is contraindicated and may worsen the condition.